Platelet function in patients with obstructive sleep apnea syndrome characterized by means of membrane bound P-selectin expression

H. J. Seyfarth, M. Donnè, V. Werling, A. Bosse-Henck, J. Schauer, H. Wirtz (Leipzig, Germany)

Source: Annual Congress 2002 - Sleep apnoea as a systemic disease
Session: Sleep apnoea as a systemic disease
Session type: Oral Presentation
Number: 1417
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. J. Seyfarth, M. Donnè, V. Werling, A. Bosse-Henck, J. Schauer, H. Wirtz (Leipzig, Germany). Platelet function in patients with obstructive sleep apnea syndrome characterized by means of membrane bound P-selectin expression. Eur Respir J 2002; 20: Suppl. 38, 1417

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease (overlap syndrome)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovasculer diseases
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011

Influence of micropaticles harvested from patients affected by obstructive sleep apnea syndrome on endothelial function and vascular reactivity
Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing
Year: 2009

Mean platelet volume in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010

Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006

The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005

Circulating microparticles and endothelial dysfunction in obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 564s
Year: 2004

The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012

Mean platelet volume in obstructive sleep apnea patients. Another link to cardiovascular disease?
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003


Endothelial function in obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011

Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 216s
Year: 2001

C-reactive protein levels in obstructive sleep apnea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 356s
Year: 2005

Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 331s
Year: 2004

Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

S100B protein: A useful marker in obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012


Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005